Home / Signaling Pathways / Archive by category "Angiogenesis"

Angiogenesis

Angiogenesis is the process by which new blood vessels are formed from pre-existing vessels. It plays a crucial role in various physiological processes such as wound healing, embryonic development, and the menstrual cycle. Additionally, angiogenesis is a key component of tumor growth and metastasis, making it a target for anti-cancer therapies.

Angiogenesis is regulated by a complex network of signaling pathways that control the proliferation and migration of endothelial cells, the building blocks of blood vessels. These pathways are activated by various growth factors, cytokines, and enzymes, which stimulate the formation of new blood vessels. One of the most well-known angiogenic signaling pathways is the vascular endothelial growth factor (VEGF) pathway, which plays a central role in promoting angiogenesis in both physiological and pathological conditions.

Understanding the signaling pathways involved in angiogenesis is crucial for developing targeted therapeutics for diseases such as cancer, cardiovascular disorders, and chronic wounds. By targeting specific molecules within these pathways, researchers hope to inhibit abnormal angiogenesis and potentially halt disease progression. Additionally, angiogenesis research may lead to new breakthroughs in regenerative medicine and tissue engineering, offering new treatment options for a wide range of medical conditions.

Product Search

Image
TCS 2314, B5492, C28H34N4O6, integrin very late antigen-4 (VLA-4; α4β1) antagonist
Image
Echistatin, α1 isoform, B5391, C217H341N71O74S9, Potent irreversible αVβ3 integrin antagonist
Image
CWHM-12, B4862, C26H32BrN5O6, inhibitor of αV integrins
Image
RGD (Arg-Gly-Asp) Peptides, B3708, C12H22N6O6, Inhibits integrin binding to RGD motifs
Image
Btk inhibitor 1 R enantiomer, B3243, C22H22N6O, Btk kinase inhibitor
Image
PCI-32765 Racemate, B3242, C25H24N6O2, BTK inhibitor
Image
Btk inhibitor 1 R enantiomer, B3243, C22H22N6O, Btk kinase inhibitor
Image
PCI-32765 Racemate, B3242, C25H24N6O2, BTK inhibitor
Image
Plinabulin (NPI-2358), B2298, C19H20N4O2, vascular disrupting agent
Image
Plinabulin (NPI-2358), B2298, C19H20N4O2, vascular disrupting agent

We are here to help

Whether you are looking to place an order or simply want to learn more about our extensive range of products, we are here to assist you every step of the way.

Quotation request